Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurodermatitis, Atopic”

1,577 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,577 results

Not applicableLooking for participantsNCT06943469
What this trial is testing

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Who this might be right for
Atopic Dermatitis (AD)
Société des Produits Nestlé (SPN) 400
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Post-approval studies (Phase 4)Study completedNCT01063218
What this trial is testing

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

Who this might be right for
Dermatitis, Atopic
Galderma Brasil Ltda. 74
Early research (Phase 1)Looking for participantsNCT07262983
What this trial is testing

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

Who this might be right for
Hyper IgE Syndrome From STAT3 MutationJob s SyndromeHIES+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT05369403
What this trial is testing

Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 86
Large-scale testing (Phase 3)Study completedNCT04875169
What this trial is testing

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 336
Large-scale testing (Phase 3)Study completedNCT03297502
What this trial is testing

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Par Pharmaceutical, Inc. 582
Not applicableUnknownNCT04681300
What this trial is testing

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Who this might be right for
Prurigo NodularisAtopic Dermatitis
Assistance Publique - Hôpitaux de Paris 20
Early research (Phase 1)Ended earlyNCT07146971
What this trial is testing

Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Good Molecules, LLC 3
Not applicableStudy completedNCT02589392
What this trial is testing

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 120
Not applicableEnded earlyNCT01826630
What this trial is testing

Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Who this might be right for
EczemaHand EczemaAtopic Dermatitis
Shari L Hand 4
Large-scale testing (Phase 3)Ended earlyNCT04140695
What this trial is testing

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Who this might be right for
Atopic Dermatitis
Vanda Pharmaceuticals 87
Testing effectiveness (Phase 2)Study completedNCT06923228
What this trial is testing

Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 3
Testing effectiveness (Phase 2)Study completedNCT03903822
What this trial is testing

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 292
Not applicableStudy completedNCT05969730
What this trial is testing

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mazandaran University of Medical Sciences 40
Not applicableLooking for participantsNCT07525505
What this trial is testing

Nigella Sativa Oil for Eczematous Otitis Externa

Who this might be right for
Eczema/Atopic DermatitisOtitis Externa
Bezmialem Vakif University 85
Testing effectiveness (Phase 2)Study completedNCT02583022
What this trial is testing

Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amorepacific Corporation 74
Testing effectiveness (Phase 2)Study completedNCT06810050
What this trial is testing

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Testing effectiveness (Phase 2)Study completedNCT04839380
What this trial is testing

The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 49
Next Page